3.1.2 Exenatide As the first GLP-1R agonist approved for T2DM, EX is a new class of compound and a synthetic product of exendin-4, which is a compound naturally derived from the Gila monster and has multiple hypoglycemic mechanisms: inhibiting of glucagon release from cells, slowing of gastric emptying, decreasing appetite and increasing glucose-dependent insulin secretion ( Lipotoxicity induced by saturated free fatty acids plays a vital role in renal injury in obese patients ( There is little research on the weight loss effect of EX on simple obesity patients, and more clinical trials are conducted on patients with T2DM
Rights and permissions About this article Cite this article Yamamoto, E
Optum Perks is owned by RVO Health
E., Amato, A., Bozzolo, H., Hollway, J., Cook, A., Ramadan, Y., Crowl, L., Zhang, D., Thompson, S., Testa, G., Kliewer, V., Wigal, T., McBurnett, K., and Manos, M
How Are Autism and Dyslexia Similar
Furthermore, they demonstrated clinically relevant benefits, including a reduced requirement for exogenous pulmonary surfactant (both in the number of infants needing treatment and the total dose administered) and a shortened duration of mechanical ventilation compared to the placebo group (73)